CMO eyes clinical trials; BearingPoint, Bovis Lend Lease target Emerald Isle;

> New York contract manufacturer Norwich Pharmaceuticals has invested in the infrastructure, controls and specialized equipment necessary for pilot-scale formulation and the manufacture of clinical trial materials. Announcement

> Tech consultancy BearingPoint and construction management company Bovis Lend Lease have teamed to support the pharmaceutical and medical technology sectors in Ireland. Release

> Shanghai-based WuXi PharmaTech has named Wei-Min Chang has been appointed Vice President of Operations and General Manager of the company's SynTheAll manufacturing facility, where it makes active pharmaceutical ingredients and advanced intermediates for use in preclinical and clinical trials. The company recently completed construction of an expanded facility, known as SynTheAll Phase 2, to produce advanced intermediates and APIs for late-stage clinical trials and commercial supplies. Release

> A mid- to high-level production double-sided tablet press boasts 49 stations, touch-screen controls, automatic weight control and removable turret capabilities. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.